NCT00665210

Brief Summary

Hip implants come in different sizes. Currently, surgeons predict the implant size that will be needed using an analogue method whereby photos of the implant sizes are overlaid on the x-rays. In this study, we propose to use a digital, computerized method of templating which we expect will be more accurate than the overlay method.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 23, 2008

Completed
Last Updated

October 26, 2011

Status Verified

October 1, 2011

First QC Date

April 21, 2008

Last Update Submit

October 24, 2011

Conditions

Keywords

hip arthritisimplant sizing

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients booked for primary total hip arthroplasty with non-cemented prosthesis

You may qualify if:

  • Patients booked for primary total hip arthroplasty with non-cemented prosthesis.
  • No previous surgery/fractures to acetabulum or femur or hip.
  • No gross bony abnormality except for osteoarthritis and avascular necrosis.

You may not qualify if:

  • Cancer or tumor suspected, morbid obesity, revision, previous acetabular/femur/hip surgery, gross bony deformity, calibration bar not completely pictured on radiograph, unsuccessful surgery fracture/cancer/cemented prosthesis used.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OHRI

Ottawa, Ontario, K1Y 4E9, Canada

RECRUITING

Study Officials

  • Peter Thurston, MD

    Ottawa Hospital Research Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Thurston, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2008

First Posted

April 23, 2008

Study Start

October 1, 2007

Last Updated

October 26, 2011

Record last verified: 2011-10

Locations